<DOC>
	<DOC>NCT02706821</DOC>
	<brief_summary>The investigators performed a 8-week, randomized, double-blind, placebo-controlled crossover human trial to evaluate the efficacy and safety of persimmon leaf extract on blood glucose. The investigators measures changes in diabetes associated parameters, including fasting blood glucose, postprandial blood glucose, insulin, C-peptide and HbA1c.</brief_summary>
	<brief_title>Anti-diabetic Effects of Persimmon Leaf Extract</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Age 2075 years Fasting blood glucose (FPG) 100~140 mg/dL or postprandial blood glucose (PPG) 140~250 mg/dL FPG more than 140 mg/dL 2h PPG more than 200 mg/dL Type 1 diabetes or HbA1c more than 9.0% treatment with corticosteroids within the past 4 weeks cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>prediabetes</keyword>
	<keyword>blood glucose</keyword>
	<keyword>clinical trial</keyword>
</DOC>